Kantarjian, H. Acute myeloid leukemia—major progress over four decades and glimpses into the future. Am. J. Hematol. 91, 131–145 (2016).

Article  PubMed  Google Scholar 

Short, N. J., Rytting, M. E. & Cortes, J. E. Acute myeloid leukaemia. Lancet 392, 593–606 (2018).

Article  PubMed  PubMed Central  Google Scholar 

DeWolf, S. & Tallman, M. S. How I treat relapsed or refractory AML. Blood 136, 1023–1032 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Ganzel, C. et al. Very poor long-term survival in past and more recent studies for relapsed AML patients: the ECOG-ACRIN experience. Am. J. Hematol. 93, 1074–1081 (2018).

Article  PubMed  PubMed Central  Google Scholar 

Perl, A. E. et al. Gilteritinib or chemotherapy for relapsed or refractory FLT3-mutated AML. N. Engl. J. Med. 381, 1728–1740 (2019).

Article  CAS  PubMed  Google Scholar 

Frey, N. V. et al. Optimizing chimeric antigen receptor T-cell therapy for adults with acute lymphoblastic leukemia. J. Clin. Oncol. 38, 415–422 (2020).

Article  CAS  PubMed  Google Scholar 

Maude, S. L. et al. Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia. N. Engl. J. Med. 378, 439–448 (2018).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pasquini, M. C. et al. Real-world evidence of tisagenlecleucel for pediatric acute lymphoblastic leukemia and non-Hodgkin lymphoma. Blood Adv. 4, 5414–5424 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shah, B. D. et al. KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study. Lancet 398, 491–502 (2021).

Article  CAS  PubMed  Google Scholar 

Epperly, R., Giordani, V. M., Mikkilineni, L. & Shah, N. N. Early and late toxicities of chimeric antigen receptor T-cells. Hematol. Oncol. Clin. North Am. 37, 1169–1188 (2023).

Article  PubMed  Google Scholar 

Bendall, L. J., Daniel, A., Kortlepel, K. & Gottlieb, D. J. Bone marrow adherent layers inhibit apoptosis of acute myeloid leukemia cells. Exp. Hematol. 22, 1252–1260 (1994).

CAS  PubMed  Google Scholar 

Garrido, S. M., Appelbaum, F. R., Willman, C. L. & Banker, D. E. Acute myeloid leukemia cells are protected from spontaneous and drug-induced apoptosis by direct contact with a human bone marrow stromal cell line (HS-5). Exp. Hematol. 29, 448–457 (2001).

Article  CAS  PubMed  Google Scholar 

Bruner et al. Adaptation to TKI treatment reactivates ERK signaling in tyrosine kinase-driven leukemias and other malignancies. Cancer Res. 77, 5554–5563 (2017).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sung, P. J., Sugita, M., Koblish, H., Perl, A. E. & Carroll, M. Hematopoietic cytokines mediate resistance to targeted therapy in FLT3-ITD acute myeloid leukemia. Blood Adv. 3, 1061–1072 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang, X., Sexauer, A. & Levis, M. Bone marrow stroma-mediated resistance to FLT3 inhibitors in FLT3-ITD AML is mediated by persistent activation of extracellular regulated kinase. Br. J. Haematol. 164, 61–72 (2014).

Article  CAS  PubMed  Google Scholar 

Lehtonen, A., Matikainen, S., Miettinen, M. & Julkunen, I. Granulocyte–macrophage colony-stimulating factor (GM-CSF)-induced STAT5 activation and target-gene expression during human monocyte/macrophage differentiation. J. Leukoc. Biol. 71, 511–519 (2002).

Article  CAS  PubMed  Google Scholar 

Liao, Z. et al. Structure-based screen identifies a potent small molecule inhibitor of Stat5a/b with therapeutic potential for prostate cancer and chronic myeloid leukemia. Mol. Cancer Ther. 14, 1777–1793 (2015).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Okada, K. et al. FLT3-ITD induces expression of Pim kinases through STAT5 to confer resistance to the PI3K/Akt pathway inhibitors on leukemic cells by enhancing the mTORC1/Mcl-1 pathway. Oncotarget 9, 8870–8886 (2018).

Article  PubMed  Google Scholar 

Wang, Q. S. et al. Treatment of CD33-directed chimeric antigen receptor-modified T cells in one patient with relapsed and refractory acute myeloid leukemia. Mol. Ther. 23, 184–191 (2015).

Article  CAS  PubMed  Google Scholar 

Yao, S. et al. Donor-derived CD123-targeted CAR T cell serves as a RIC regimen for haploidentical transplantation in a patient with FUS-ERG+ AML. Front. Oncol. 9, 1358 (2019).

Article  PubMed  PubMed Central  Google Scholar 

Lamble, A. J. et al. CD123 expression is associated with high-risk disease characteristics in childhood acute myeloid leukemia: a report from the Children’s Oncology Group. J. Clin. Oncol. 40, 252–261 (2022).

Article  CAS  PubMed  Google Scholar 

Vergez, F. et al. High levels of CD34+CD38low/−CD123+ blasts are predictive of an adverse outcome in acute myeloid leukemia: a Groupe Ouest-Est des Leucemies Aigues et Maladies du Sang (GOELAMS) study. Haematologica 96, 1792–1798 (2011).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gill, S. et al. Preclinical targeting of human acute myeloid leukemia and myeloablation using chimeric antigen receptor-modified T cells. Blood 123, 2343–2354 (2014).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mardiros, A. et al. T cells expressing CD123-specific chimeric antigen receptors exhibit specific cytolytic effector functions and antitumor effects against human acute myeloid leukemia. Blood 122, 3138–3148 (2013).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ruella, M. et al. Dual CD19 and CD123 targeting prevents antigen-loss relapses after CD19-directed immunotherapies. J. Clin. Invest. 126, 3814–3826 (2016).

Article  PubMed  PubMed Central  Google Scholar 

Faderl, S. et al. Granulocyte-macrophage colony-stimulating factor (GM-CSF) induces antiapoptotic and proapoptotic signals in acute myeloid leukemia. Blood 102, 630–637 (2003).

Article  CAS  PubMed  Google Scholar 

Krevvata, M. et al. Cytokines increase engraftment of human acute myeloid leukemia cells in immunocompromised mice but not engraftment of human myelodysplastic syndrome cells. Haematologica 103, 959–971 (2018).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dohner, H. et al. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood 140, 1345–1377 (2022).

Article  PubMed  Google Scholar 

Bradbury, D., Zhu, Y. M. & Russell, N. Regulation of Bcl-2 expression and apoptosis in acute myeloblastic leukaemia cells by granulocyte-macrophage colony-stimulating factor. Leukemia 8, 786–791 (1994).

CAS  PubMed  Google Scholar 

Dumas, P. Y. et al. Hematopoietic niche drives FLT3-ITD acute myeloid leukemia resistance to quizartinib via STAT5-and hypoxia-dependent upregulation of AXL. Haematologica 104, 2017–2027 (2019).

Article  CAS  PubMed  PubMed Central